Selective targeting of apoptotic cells

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/36 (2006.01) A61K 9/00 (2006.01) A61K 9/48 (2006.01) A61K 47/00 (2006.01) A61K 47/04 (2006.01) A61K 47/44 (2006.01) A61K 47/48 (2006.01) A61P 9/10 (2006.01) A61P 19/00 (2006.01) A61P 35/00 (2006.01) A61K 47/06 (2006.01) A61K 47/10 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2466303

The invention relates to a method of selectively targeting an active agent (or agent capable of becoming an active agent) to apoptotic cells in a vertebrate, comprising administering to said vertebrate a system comprising an arsenoxide (or arsenoxide equivalent) compound and said agent, wherein said system selectively targets apoptotic cells.

L'invention se rapporte à un procédé de ciblage sélectif d'un principe actif (ou agent capable de se transformer en principe actif) vers des cellules apoptiques chez un vertébré, qui consiste à administrer à un vertébré un système comprenant un procédé arsenoxide (ou équivalent arsenoxide) et ledit agent, ledit système ciblant de manière sélective les cellules apoptiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Selective targeting of apoptotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective targeting of apoptotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective targeting of apoptotic cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1583365

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.